First Trust Nasdaq Pharmaceuticals ETF (FTXH)
Holdings of the Fund as of 9/14/2026

Total Number of Holdings (excluding cash): 49

Security Name Identifier CUSIP Classification Shares / Quantity Market Value Weighting Descending sort
Merck & Co., Inc. MRK 58933Y105 Pharmaceuticals 544,360 $78,850,546.00 7.51%
AbbVie Inc. ABBV 00287Y109 Pharmaceuticals 290,461 $76,033,975.97 7.25%
Eli Lilly and Company LLY 532457108 Pharmaceuticals 63,872 $72,704,220.16 6.93%
Johnson & Johnson JNJ 478160104 Pharmaceuticals 271,402 $72,279,780.64 6.89%
Bristol-Myers Squibb Company BMY 110122108 Pharmaceuticals 1,080,978 $69,290,689.80 6.60%
Biogen Inc. BIIB 09062X103 Biotechnology 175,621 $38,172,980.56 3.64%
Viatris Inc. VTRS 92556V106 Pharmaceuticals 2,257,753 $37,614,164.98 3.58%
Vertex Pharmaceuticals Incorporated VRTX 92532F100 Pharmaceuticals 67,972 $35,312,133.72 3.37%
Cardinal Health, Inc. CAH 14149Y108 Drug Retailers 147,276 $34,593,659.64 3.30%
Regeneron Pharmaceuticals, Inc. REGN 75886F107 Biotechnology 43,252 $34,330,842.48 3.27%
Pfizer Inc. PFE 717081103 Pharmaceuticals 1,219,007 $33,790,874.04 3.22%
Amgen Inc. AMGN 031162100 Pharmaceuticals 87,024 $33,199,656.00 3.16%
Gilead Sciences, Inc. GILD 375558103 Pharmaceuticals 226,097 $33,102,861.77 3.15%
Incyte Corporation INCY 45337C102 Biotechnology 208,588 $25,487,367.72 2.43%
Jazz Pharmaceuticals Plc JAZZ G50871105 Pharmaceuticals 101,979 $25,073,576.73 2.39%
United Therapeutics Corporation UTHR 91307C102 Pharmaceuticals 49,942 $25,105,843.40 2.39%
Illumina, Inc. ILMN 452327109 Biotechnology 111,746 $23,266,634.66 2.22%
Zoetis Inc. ZTS 98978V103 Pharmaceuticals 256,992 $18,932,600.64 1.80%
Charles River Laboratories International, Inc. CRL 159864107 Biotechnology 64,890 $17,722,107.90 1.69%
Exelixis, Inc. EXEL 30161Q104 Biotechnology 313,636 $17,629,479.56 1.68%
Halozyme Therapeutics, Inc. HALO 40637H109 Biotechnology 152,941 $16,508,451.54 1.57%
Medpace Holdings, Inc. MEDP 58506Q109 Biotechnology 26,272 $15,642,611.52 1.49%
10X Genomics, Inc. (Class A) TXG 88025U109 Biotechnology 201,352 $14,116,788.72 1.35%
Twist Bioscience Corporation TWST 90184D100 Biotechnology 98,876 $13,323,541.00 1.27%
BioMarin Pharmaceutical Inc. BMRN 09061G101 Pharmaceuticals 192,620 $12,791,894.20 1.22%
Moderna, Inc. MRNA 60770K107 Biotechnology 86,521 $12,691,765.49 1.21%
Neurocrine Biosciences, Inc. NBIX 64125C109 Biotechnology 80,335 $12,630,268.70 1.20%
Alkermes Plc ALKS G01767105 Pharmaceuticals 255,454 $11,707,456.82 1.12%
PTC Therapeutics, Inc. PTCT 69366J200 Biotechnology 166,341 $11,058,349.68 1.05%
Travere Therapeutics, Inc. TVTX 89422G107 Pharmaceuticals 155,535 $10,232,647.65 0.98%
Spyre Therapeutics, Inc. SYRE 00773J202 Biotechnology 107,644 $9,774,075.20 0.93%
Guardant Health, Inc. GH 40131M109 Biotechnology 49,436 $8,297,338.24 0.79%
TG Therapeutics, Inc. TGTX 88322Q108 Biotechnology 153,990 $8,315,460.00 0.79%
Elanco Animal Health Incorporated ELAN 28414H103 Pharmaceuticals 333,213 $7,713,880.95 0.74%
Protagonist Therapeutics, Inc. PTGX 74366E102 Biotechnology 50,463 $7,457,422.14 0.71%
Amneal Pharmaceuticals, Inc. AMRX 03168L105 Pharmaceuticals 396,043 $6,819,860.46 0.65%
Roivant Sciences Ltd. ROIV G76279101 Biotechnology 160,167 $6,570,050.34 0.63%
Ligand Pharmaceuticals Inc. (Class B) LGND 53220K504 Biotechnology 23,186 $6,507,150.90 0.62%
Arrowhead Pharmaceuticals, Inc. ARWR 04280A100 Biotechnology 79,816 $6,438,756.72 0.61%
Kymera Therapeutics, Inc. KYMR 501575104 Biotechnology 50,972 $5,842,920.36 0.56%
Krystal Biotech, Inc. KRYS 501147102 Biotechnology 16,985 $5,775,409.55 0.55%
Arcus Biosciences, Inc. RCUS 03969F109 Biotechnology 227,628 $5,479,005.96 0.52%
ACADIA Pharmaceuticals Inc. ACAD 004225108 Biotechnology 188,991 $5,201,032.32 0.50%
Mirum Pharmaceuticals, Inc. MIRM 604749101 Biotechnology 50,457 $4,881,714.75 0.47%
Tarsus Pharmaceuticals, Inc. TARS 87650L103 Biotechnology 61,291 $4,900,215.45 0.47%
Arcutis Biotherapeutics, Inc. ARQT 03969K108 Biotechnology 172,003 $4,174,512.81 0.40%
Alnylam Pharmaceuticals, Inc. ALNY 02043Q107 Biotechnology 13,906 $3,476,360.94 0.33%
Supernus Pharmaceuticals, Inc. SUPN 868459108 Pharmaceuticals 84,474 $3,504,826.26 0.33%
Ionis Pharmaceuticals, Inc. IONS 462222100 Pharmaceuticals 57,163 $2,940,464.72 0.28%
US Dollar $USD Other 2,032,975 $2,032,974.73 0.19%
Holdings are subject to change.

The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.